Literature DB >> 30843116

Cancer and motor neuron disease-causal or coincidental? Two contrasting cases.

John Goodfellow1, George Gorrie2, Veronica Leach3, Sameer Patel4, Graham Mackay5.   

Abstract

INTRODUCTION: Motor neuron disease (MND) can occur in patients with cancer, but there is minimal evidence that this is more than by chance. We contrast two cases of motor neuronopathies occurring in the context of systemic malignancy and argue that in one case the cause was most likely paraneoplastic, while in the other it was not. CASE 1: A 61-year-old woman developed progressive walking difficulties over 9 months with weakness and stiffness in her legs. EMG showed fibrillations and positive sharp waves in multiple lower limb muscles bilaterally, with neurogenic units and a reduced recruitment pattern. An invasive ductal carcinoma of the breast was identified and she continued to deteriorate neurologically with worsening mobility, upper limb spasticity and fasciculations. She died approximately 26 months after symptom onset. CASE 2: A 57-year-old woman developed weight loss and weakness of her right arm without any sensory symptoms. At presentation, she had wasting and fasciculations in her right upper limb muscles, with normal reflexes, normal left upper limb and lower limb examination. Over the following week, she developed left upper limb weakness and fasciculations, brisk knee reflexes, and flexor plantar responses. Her EMG showed upper and lower limb denervation. She was found to have anti-Hu and anti-CV2 antibodies present in serum. A PET-CT showed active uptake in lymph nodes in the right hilum. Biopsy confirmed a small cell lung cancer. She had chemoradiation therapy and the tumour went into remission. She has remained well on follow-up 24 months later, regaining weight and strength after her chemotherapy. She continues to be monitored for cancer recurrence, but thus far appears to be in remission.
CONCLUSION: In cases with rapidly progressive MND, particularly of upper limb onset, consideration should be given to testing anti-neuronal antibodies and searching for an occult tumour.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Cancer; Lower motor neurone signs; Motor neuron disease; Paraneoplastic; Upper motor neurone signs

Mesh:

Year:  2019        PMID: 30843116     DOI: 10.1007/s10072-019-03784-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.

Authors:  Oliver Stich; Barbara Kleer; Sebastian Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

3.  Brachial amyotrophic diparesis associated with anti-Hu positive anterior horn cell disease and autonomic disorder.

Authors:  John-Ih Lee; Stephan Macht; Philipp Albrecht; Hans-Peter Hartung; Norbert Goebels
Journal:  J Neurol       Date:  2012-11-08       Impact factor: 4.849

4.  Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

Authors:  M J Titulaer; R Soffietti; J Dalmau; N E Gilhus; B Giometto; F Graus; W Grisold; J Honnorat; P A E Sillevis Smitt; R Tanasescu; C A Vedeler; R Voltz; J J G M Verschuuren
Journal:  Eur J Neurol       Date:  2010-09-29       Impact factor: 6.089

Review 5.  Which antibody and which cancer in which paraneoplastic syndromes?

Authors:  Paul Gozzard; Paul Maddison
Journal:  Pract Neurol       Date:  2010-10

Review 6.  Motor neuron disease of paraneoplastic origin: a rare but treatable condition.

Authors:  Nicolas Mélé; Giulia Berzero; Thierry Maisonobe; François Salachas; Guillaume Nicolas; Nicolas Weiss; Guillemette Beaudonnet; Francois Ducray; Dimitri Psimaras; Timothée Lenglet
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

7.  The association between cancer and amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Rochelle E Curtis; Sarah E Daugherty; James J Goedert; Ralph W Kuncl; Margaret A Tucker
Journal:  Cancer Causes Control       Date:  2012-10-23       Impact factor: 2.506

Review 8.  Is there a paraneoplastic ALS?

Authors:  Philippe Corcia; Paul H Gordon; Jean-Philippe Camdessanche
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-06       Impact factor: 4.092

9.  Utility of Paraneoplastic Antibody Testing in the Diagnosis of Motor Neuron Disease.

Authors:  Najwa Al-Bustani; William Simonson; Desiree A Marshall; Jennifer Vetrovs; Mark H Wener; Michael D Weiss; Leo H Wang
Journal:  J Clin Neuromuscul Dis       Date:  2015-12

10.  Population-based risks for cancer in patients with ALS.

Authors:  Summer B Gibson; Diana Abbott; James M Farnham; Khanh K Thai; Hailey McLean; Karla P Figueroa; Mark B Bromberg; Stefan M Pulst; Lisa Cannon-Albright
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

View more
  1 in total

1.  Paraneoplastic Amyotrophic Lateral Sclerosis: Case Series and Literature Review.

Authors:  Zhao Yang; Lu He; Manli Ren; Yizhou Lu; Huanyu Meng; Dou Yin; Sheng Chen; Qinming Zhou
Journal:  Brain Sci       Date:  2022-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.